Roundup Lawsuit Filed Over New Diagnosis of NHL, Following Years of Exposure to the Weedkiller
Bayer and Monsanto face more than 120,000 claims over Roundup exposure nationwide.
Bayer and Monsanto face more than 120,000 claims over Roundup exposure nationwide.
Widespread exposure to the pesticide 2,4-D has been linked to increased cancer risks and other health issues.
A Canadian federal court determined Health Canada did not follow its own rules in re-approving the controversial weed killer.
Plaintiffs say the lack of cancer warnings meant consumers were deceived about the value of Roundup and thus paid too much for the controversial weed killer.
If the court sides with plaintiffs, it could force the EPA to re-evaluate the safety of Roundup or even call for the weed killer to be banned from use in the U.S.
Simply registering the weed killer with the EPA does not provide Bayer or Monsanto with liability protection, the federal judge determined
Bayer's acquisition of Monsanto included acquiring 125,000 Roundup cancer lawsuits which may cost the company billions of dollars to settle, which investors say was a risk they should have been informed about.
Bayer holds hope that a favorable Supreme Court decision will declare it exempt from Roundup lawsuits based on federal regulators' approval of the popular weed killer.
This is only the second court victory for Roundup lawsuit defendants after a string of losses over the last several years, and the first successful defense involving direct application of Roundup.
Determinations by the EPA and other agencies could lead to new restrictions and label warnings on Roundup and other pesticides.